Moriwaki Y, Yamamoto T, Nasako Y, Ohata H, Takahashi S, Tsutsumi Z, Yamakita J, Higashino K
Third Department of Internal Medicine, Hyogo College of Medicine, Japan.
Ann Clin Biochem. 1999 Jul;36 ( Pt 4):501-3. doi: 10.1177/000456329903600414.
Urinary excretion of uric acid was found to be extremely low in a 58-year-old female patient with alcaptonuria. This was due to interference with the uricase-peroxidase method used, because analysis using high-performance liquid chromatography (HPLC) showed a normal urinary concentration of uric acid. In vitro experiments demonstrated that a high concentration of homogentisic acid in the patient's urine inhibited the peroxidase reaction, possibly due to inhibition of the colour development of 3-methyl-N-ethyl-N-(beta-hydroxyethyl)aniline (MEHA) and 4-aminoantipyrine, via the peroxidase reaction. A homogentisic acid concentration equivalent to that in plasma did not affect the uricase-peroxidase reaction. This result suggests that any assay based on a peroxidase method is affected by a high urinary concentration of homogentisic acid in patients with alcaptonuria.
在一名58岁的患黑尿症女性患者中,发现尿酸的尿排泄量极低。这是由于所用尿酸酶-过氧化物酶方法受到干扰,因为使用高效液相色谱法(HPLC)分析显示尿中尿酸浓度正常。体外实验表明,患者尿液中高浓度的尿黑酸抑制了过氧化物酶反应,这可能是由于通过过氧化物酶反应抑制了3-甲基-N-乙基-N-(β-羟乙基)苯胺(MEHA)和4-氨基安替比林的显色。与血浆中浓度相当的尿黑酸浓度并不影响尿酸酶-过氧化物酶反应。这一结果表明,基于过氧化物酶方法的任何检测都会受到黑尿症患者尿中高浓度尿黑酸的影响。